立体定向脑电图用于考虑手术的药物难治性癫痫患者:系统评价、Meta分析与经济学评价
该系统评价与Meta分析评估立体定向脑电图(SEEG)在药物难治性癫痫考虑手术患者中定位致痫区的有效性、安全性与成本效果;Markov模型从西班牙国家卫生服务视角模拟终生成本和健康结局,结果显示SEEG较不做SEEG干预可提高质量调整生命年且增量成本效果比为每QALY 10 368欧元。
要点
- 接受SEEG的患者中92%定位到致痫区,72%符合癫痫手术条件,33%术后无癫痫发作。
- 接受手术的患者中47%术后无癫痫发作。
- SEEG植入、监测及后续干预相关并发症发生率为1.3%。
核心结论
- 与不做SEEG干预相比,SEEG在考虑手术的药物难治性癫痫患者中具有成本效果。
研究设计与样本
- 系统评价与Meta分析评估SEEG的有效性和安全性。
- 采用Markov模型进行成本效果分析,从西班牙国家卫生服务视角模拟个体终生成本和健康结局。
- 效果指标为质量调整生命年(QALYs)。
- 进行了广泛的敏感性分析,包括概率敏感性分析。
主要发现
- 接受SEEG的患者中92%定位到致痫区(95%CI:0.87-0.96)。
- 接受SEEG的患者中72%符合癫痫手术条件(95%CI:0.66-0.78)。
- 接受SEEG的患者中33%术后无癫痫发作(95%CI:0.27-0.42)。
- 接受手术的患者中47%术后无癫痫发作(95%CI:0.37-0.58)。
- SEEG植入、监测及后续干预相关并发症发生率为1.3%(95%CI:0.01-0.02)。
关键数值与推荐
- 基础病例分析中,SEEG导致更高的QALYs和更高的医疗成本,增量成本效果比为每QALY 10 368欧元(95%CI:优势-113 911)。
- SEEG具有成本效果的概率在75%至88%之间。
- 进一步的敏感性分析显示研究结果稳健。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stereoelectroencephalography (SEEG) has been shown to be a valuable tool for the anatomoelectroclinical definition of the epileptogenic zone (EZ) in patients with medically refractory epilepsy considered for surgery (RES patients). In Spain, many of those patients are not offered this diagnostic procedure. OBJECTIVE: To evaluate the effectiveness, safety, and cost-effectiveness of SEEG to define the EZ in RES patients compared to no SEEG intervention, ie, remaining with further antiepileptic drugs. METHODS: We undertook a systematic review with meta-analyses on the effectiveness and safety of SEEG. A cost-effectiveness analysis was conducted using a Markov model, which simulates the costs and health outcomes of individuals for a lifetime horizon from the perspective of the Spanish National Health Service. The effectiveness measure was quality-adjusted life years (QALYs). We ran extensive sensitivity analyses, including a probabilistic sensitivity analysis. RESULTS: The EZ was found in 92% of patients who underwent SEEG (95% confidence interval [CI]: 0.87-0.96); 72% were eligible for epilepsy surgery (95% CI: 0.66-0.78) and 33% were free of seizures after surgery (95% CI: 0.27-0.42). Of the patients who underwent surgery, 47% were free of seizures after surgery (95% CI: 0.37-0.58). Complications related to implantation and monitoring of SEEG and the subsequent intervention occurred in 1.3% of patients (95% CI: 0.01-0.02). In the base case analysis, SEEG led to higher QALYs and healthcare costs with an estimated incremental cost-effectiveness ratio of 10 368 EUR per QALY (95% CI: dominant-113 911), making the probability of cost-effectiveness between 75% and 88%. Further sensitivity analyses showed that the results of the study were robust. CONCLUSION: SEEG is a cost-effective technology in RES patients when compared to no SEEG intervention.
引用
- Garcia-Lorenzo B, Del Pino-Sedeño T, Rocamora R, et al. Stereoelectroencephalography for Refractory Epileptic Patients Considered for Surgery: Systematic Review, Meta-Analysis, and Economic Evaluation. Neurosurgery. 2019. PMID: 29982799. doi:10.1093/neuros/nyy261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。